Black Diamond Therapeutics, Inc.

BDTXNASDAQHealthcare● Active

$1.85

$-0.12(-6.09%)

Market Cap$106008282

P/E Ratio—

52W High$4.94

52W Low$1.85

Avg Volume1.2M

Open$2.00

Beta3.23

Employees Ownership Insider Trades

Black Diamond Therapeutics, Inc. (BDTX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · BDTX · as of Mar 16, 2026

Latest filing snapshot

-3-12.50%vs prior year

Black Diamond Therapeutics, Inc. (BDTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-3

Growth % (1Y)

-12.50%

Revenue / Employee

$3.33M

Net Income / Employee

$1.07M

Market Cap

$106M

BDTX Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-16	2025-12-31	21	-3	-12.50%
2025-03-06	2024-12-31	24	-30	-55.56%
2024-03-12	2023-12-31	54	-11	-16.92%
2023-03-09	2022-12-31	65	-23	-26.14%
2022-03-17	2021-12-31	88	+15	+20.55%
2021-03-25	2020-12-31	73	+41	+128.13%
2020-03-24	2019-12-31	32	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CRBU

Caribou Biosciences, Inc.

147$182M #2

ABEO

Abeona Therapeutics Inc.

136$307M #3

ENTA

Enanta Pharmaceuticals, Inc.

131$257M #4

FENC

Fennec Pharmaceuticals Inc.

32$254M #5

AVTX

Avalo Therapeutics, Inc.

23$144M #6

AARD

Aardvark Therapeutics, Inc. Common Stock

22$78M #7

BDTX

Black Diamond Therapeutics, Inc.YOU

21$106M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · BDTX peer comparison

About BDTX employees

BDTX Employees · Headcount

Black Diamond Therapeutics, Inc. (BDTX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Black Diamond Therapeutics, Inc. had 21 full-time employees globally. Full-time employees only. Global consolidated headcount.

Black Diamond Therapeutics, Inc. employs 21 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $3.33M, reflecting the company's operational efficiency.

Black Diamond Therapeutics, Inc.'s workforce decreased by 3 (12.50%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Black Diamond Therapeutics, Inc.'s revenue per employee of $3.33M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

BDTX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Black Diamond Therapeutics, Inc. had 21 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Black Diamond Therapeutics, Inc. employee counthow many employees does Black Diamond Therapeutics, Inc. haveBDTX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-16